News         << back

Restech Announces New Distributor in Turkey

San Diego, California, USA – March 10, 2009 – Today, Respiratory Technology Corporation (dba Restech) announced it is partnering with Endo&Lap to sell and service the revolutionary Dx-pH Measurement System™ throughout Turkey and neighboring regions including Turks Republics, The Eastern European region, Russia and several Middle Eastern countries.

Restech’s Dx-System provides valuable information about patients’ pharyngeal acid exposure and its role in various comorbidities, helping physicians diagnose the cause of the patient’s symptoms more accurately, and treat the patient more effectively.

The Dx-pH Measurement System recently received CE Mark approval, making it available to physicians throughout Europe who have recognized a need for this technology after an alarming increase in the incidence of gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux disease (LPRD) over the last two decades.

“With the dramatic increase of patients presenting with possible symptoms of LPR, an accurate diagnosis is critical for physicians to provide appropriate treatment. It is important that we support the medical community with a highly respected local distributor,” said Leo R. Roucher, CEO, Restech. “Endo&Lap are extremely well respected in their market. They are strategically selective of the companies they represent, and are the ideal partner for this exciting stage of our development in Turkey.”

“We are thrilled by the prospect of working with Restech,” stated Cemal Yakar, CEO, Endo&Lap. “Restech has developed a revolutionary medical device that is important to physicians in our region to enable them to make more accurate diagnoses of GERD and LPRD. The company’s strong values match our own and we look forward to using our local knowledge and expertise to grow sales and enhance customer support in Turkey and other countries that we supply.”

About Endo&Lap
Endo&Lap was established in 1994 as marketing and servicing company in the medical field. The company has grown steadily despite difficult economic conditions in Turkey and highly competitive market conditions during the last 14 years.

Based in Ankara, Turkey, Endo&Lap has branch offices and company representatives in the major cities throughout the region, facilitating expeditious response to all calls throughout the market by utilizing their effective network. www.endo-lap.com.

Restech Dx–pH Measurement System
The Restech Dx–pH Measurement System is a revolutionary system that comfortably measures pH in the airway. Gastric reflux in the upper airway, or laryngopharyngeal reflux, commonly takes a gaseous form that cannot be measured using conventional technology. The miniaturized pH sensor at the tip of the Dx–pH Probe is unique in its ability to measure pH in a non-liquid environment, such as the pharynx. By monitoring the pH levels in the pharynx, the Dx–System enables physicians to confirm or deny the presence of laryngopharyngeal reflux, and evaluate it as a possible contributor to their patients’ symptoms.

The Dx–pH Probe’s miniaturized, patented sensor is housed in the tear-drop shaped tip at the distal end of a thin trans-nasal catheter. An LED blinks during placement, allowing the medical personnel to confirm the proper placement in the oropharynx. The small size and minimally invasive position of the Restech Dx–pH Probe allows patients to carry on normal, everyday activities including eating, talking and sleeping with more comfort than conventional esophageal pH probes.

The measurements taken by the pH sensor are sent wirelessly to a recording device which the patient carries throughout the study period. Upon completion of the study (usually 24 hours), the patient returns to the physician’s office where the data is downloaded and presented graphically for analysis using Restech’s custom Dx–pH DataView software.

About Restech Corporation
Restech is a leader in engineering world class medical technologies that provide comfortable, reliable solutions to assist physicians in the diagnosis of reflux related health problems quickly and reliably. The innovative engineering team at Restech is led by professionals with over two decades experience each in medical device development. Together, the Restech staff hold over 30 patents in the areas of sensor technology, data recording & monitoring systems, and other medical devices.

For more information on the Dx-pH Measurement System, please contact Ms. Debra Krahel of Restech at (800) 352-1512 or visit http://www.restech-corp.com.

Press Contact: Victoria Battison Tel: 408-779-4476 battison@vbimarketing.com